Cerium Oxide Nanoparticle Detection Device for Chronic Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cerium oxide nanoparticles, despite their antioxidant properties, pose toxicity risks due to their reactive nature and lack of clearance mechanisms in biological systems, limiting their in vivo applications, and existing methods do not effectively encapsulate them to prevent adverse side effects.
Innovation Solution
A biocompatible device with a two-chamber or single-chamber design encapsulating cerium oxide nanoparticles and fluorescent polymeric iron oxide nanoparticles, utilizing semi-permeable membranes to sense reactive oxygen species (ROS) levels, allowing ROS scavenging while protecting imaging agents from exposure, enabling monitoring of chronic inflammation and ROS detection without adverse toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cerium oxide nanoparticles are used for ROS scavenging and antioxidant protection, then antioxidant activity and cytoprotective effects are improved, but toxicity and lack of clearance mechanisms worsen
Solution Approach 1:
The patent introduces a biocompatible polymer coating as an intermediary layer between the cerium oxide nanoparticles and the biological environment. This coating serves as a mediator that prevents direct contact between the toxic nanoparticle surface and biological systems while allowing the nanoparticle to maintain its ROS scavenging function through the coating's porous structure or surface interactions.
Solution Approach 2:
The patent applies a flexible polymer shell coating around the cerium oxide nanoparticles. This thin film structure encapsulates the nanoparticle, providing a protective barrier that reduces toxicity and improves biocompatibility while maintaining the nanoparticle's antioxidant properties. The flexible nature of the polymer shell allows it to adapt to biological environments without compromising nanoparticle function.
2Reliability
If cerium oxide nanoparticles are administered freely in solution, then ROS scavenging capability is improved, but nanoparticle clearance and toxicity increase
Solution Approach 1:
The polymer coating acts as an intermediary that modifies the nanoparticle's interaction with biological systems. It prevents rapid clearance by the reticuloendothelial system while maintaining ROS scavenging capability, effectively extending the nanoparticle's residence time in the body without compromising its protective function.
Solution Approach 2:
The patent changes the surface parameters of the nanoparticle by coating it with polymer materials. This modification alters the nanoparticle's physical and chemical properties, including surface charge, hydrophobicity, and molecular size, thereby reducing recognition by clearance mechanisms while preserving the core nanoparticle's ROS scavenging activity.
3Reliability
If nanoceria are used to protect against oxidative stress, then cytoprotective effects are improved, but dephosphorylation of substrates and aberrant cell signaling worsen
Solution Approach 1:
The polymer coating serves as a protective intermediary that prevents the nanoparticle from directly interacting with cellular substrates and signaling pathways. This barrier reduces off-target effects such as dephosphorylation of proteins and aberrant cell signaling, while still allowing the nanoparticle to provide cytoprotective effects through ROS scavenging.
Solution Approach 2:
The patent applies local quality modification by creating a controlled interface between the nanoparticle and biological systems. The polymer coating provides a localized protective layer that selectively interacts with ROS while preventing direct contact with cellular components, thereby maintaining cytoprotective effects while minimizing harmful downstream effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device effectively detects ROS and monitors chronic inflammation through fluorescence and MRI changes, providing a stable and non-toxic means to sense elevated ROS levels, suitable for various inflammatory conditions and cancer therapy, while preventing nanoparticle toxicity.
Implementation Method 1
cerium oxide nanoparticles, despite being potent reactive oxygen species (ROS) scavengers
Implementation Method 2
fluorescent polymeric iron oxide nanoparticles (including Dex-IO-DiR and PAA-IO-DiI) in a two-chamber biocompatible device
Implementation Method 3
the first chamber and the second chamber joined in a non-communicating manner so that both the first chamber and the second chamber independently communicate with an aqueous environment through the exterior semi-permeable membrane of each chamber allowing the diffusion of ROS
Data Source
AI summary
A polymer-coated cerium oxide based device and system is disclosed for detecting reactive oxygen species and monitoring chronic inflammation. The device and system encapsulate free therapeutic nanoparticle elements not present in a living body in a prosthetic or implantable unit. Embodiment one is a two-chamber structure with a reactive oxygen species (ROS) scavenging component on one end and at the opposite end is an imaging agent consisting of at least one of a fluorophore capable of fluorescence emission, a chemiluminescent agent, a magnetic relaxation agent and an X-ray contrast agent. Embodiment two is a single chamber device consisting of a multifunctional nanocomposite with a ROS-scavenging nanoparticle constituent (nanoceria) and a multimodal reporting nanoparticle component (i.e. Dex-IO-DiR). The device and system are utilized in treatment of diseases with a pro-inflammatory component, including, but not limited to, Crohn's disease, ulcerative colitis, inflammatory bowel disease, cystic fibrosis, arthritis, and cancer chemotherapy.